ACLARION, INC(ACON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ACON ACLARION, INC

Market Closed 11-22 16:00:00 EST

0.1758

-0.0031

-1.73%

盘后0.1758

+0.00000.00%

18:53 EST

High0.1813	Low0.1750	Vol125.85K
Open0.1750	D1 Closing0.1789	Amplitude3.52%
Mkt Cap1.78M	Tradable Cap1.77M	Total Shares10.14M
T/O22.46K	T/O Rate1.25%	Tradable Shares10.04M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ACON","market":"US","secType":"STK","nameCN":"ACLARION, INC","latestPrice":0.1758,"timestamp":1732309200000,"preClose":0.1789,"halted":0,"volume":125847,"hourTrading":{"tag":"盘后","latestPrice":0.1758,"preClose":0.1758,"latestTime":"18:53 EST","volume":3650,"amount":647.2069,"timestamp":1732319615385},"delay":0,"floatShares":10044728,"shares":10140916,"eps":-1.05459,"marketStatus":"Market Closed","change":-0.0031,"latestTime":"11-22 16:00:00 EST","open":0.175,"high":0.1813,"low":0.175,"amount":22459.60828179,"amplitude":0.035215,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.05459,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732525200000},"marketStatusCode":7,"adr":0,"listingDate":1650600000000,"exchange":"NASDAQ","adjPreClose":0.1789,"preHourTrading":{"tag":"盘前","latestPrice":0.175,"preClose":0.1789,"latestTime":"08:27 EST","volume":3,"amount":0.5249999999999999,"timestamp":1732282043754},"postHourTrading":{"tag":"盘后","latestPrice":0.1758,"preClose":0.1758,"latestTime":"18:53 EST","volume":3650,"amount":647.2069,"timestamp":1732319615385},"volumeRatio":0.5383386691955867},"requestUrl":"/m/hq/s/ACON/wiki","defaultTab":"wiki","newsList":[{"id":"2478342915","title":"Aclarion files to sell 20M shares of common stocks by selling shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2478342915","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478342915?lang=en_us&edition=fundamental","pubTime":"2024-10-26 05:23","pubTimestamp":1729891387,"startTime":"0","endTime":"0","summary":"Aclarion (NASDAQ:ACON) filed a prospectus related to the offer and resale of about 20M shares of common stocks by selling securityholder.\nThe company will not receive any proceeds from the sale of ordinary shares by the selling shareholder.\nThis prospectus is not an offer to sell.\nFiling","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4207480-aclarion-files-to-sell-20m-shares-of-common-stocks-by-selling-shareholders","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2478962268","title":"Aclarion files to sell 20M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2478962268","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478962268?lang=en_us&edition=fundamental","pubTime":"2024-10-26 05:10","pubTimestamp":1729890611,"startTime":"0","endTime":"0","summary":"17:07 EDT Aclarion (ACON) files to sell 20M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, marke...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aclarion-files-to-sell-20m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aclarion-files-to-sell-20m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","ACON"],"gpt_icon":0},{"id":"2472538503","title":"BRIEF-Aclarion Inc Entered Into A Securities Purchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2472538503","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472538503?lang=en_us&edition=fundamental","pubTime":"2024-10-02 04:58","pubTimestamp":1727816308,"startTime":"0","endTime":"0","summary":"Aclarion Inc   :   * ACLARION INC: ENTERED INTO A SECURITIES PURCHASE AGREEMENT   * ACLARION INC: RECEIVED $1 MILLION GROSS PROCEEDS IN CONNECTION WITH FINANCINGSource text for Eikon:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2472828855","title":"Aclarion Inc: Entered Into a Securities Purchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2472828855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472828855?lang=en_us&edition=fundamental","pubTime":"2024-10-02 04:09","pubTimestamp":1727813372,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241001:nFWN3LD19P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2472582883","title":"Aclarion Inc: Received $1 Mln Gross Proceeds in Connection With Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2472582883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472582883?lang=en_us&edition=fundamental","pubTime":"2024-10-02 04:09","pubTimestamp":1727813372,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241001:nFWN3LD19P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","ACON"],"gpt_icon":0},{"id":"2470706300","title":"Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2470706300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470706300?lang=en_us&edition=fundamental","pubTime":"2024-09-27 18:58","pubTimestamp":1727434710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240927:nFWN3L90KH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2470282724","title":"Aclarion Establishes $10 Million At-The-Market Offering Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2470282724","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470282724?lang=en_us&edition=fundamental","pubTime":"2024-09-25 05:52","pubTimestamp":1727214723,"startTime":"0","endTime":"0","summary":"Aclarion (ACON) said Tuesday it plans to sell up to $10 million of its common shares from time to time through an at-the-market offering.Ascendiant Capital Markets will be the sales agent, according t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4167","ACON"],"gpt_icon":0},{"id":"2470744794","title":"BRIEF-Aclarion Announces At The Market Offering Of Up To $10 Million Of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2470744794","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470744794?lang=en_us&edition=fundamental","pubTime":"2024-09-25 05:04","pubTimestamp":1727211885,"startTime":"0","endTime":"0","summary":"Sept 24 (Reuters) - Aclarion Inc   :   * ACLARION ANNOUNCES AT THE MARKET OFFERING OF UP TO $10 MILLION OF SHARESSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACON","BK4008","UP"],"gpt_icon":0},{"id":"2470479414","title":"BRIEF-Aclarion Inc Says It May Offer, Sell Shares Of Common Stock Of Up To $1.1 Million From Time To Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2470479414","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470479414?lang=en_us&edition=fundamental","pubTime":"2024-09-25 05:04","pubTimestamp":1727211873,"startTime":"0","endTime":"0","summary":"Sept 24 (Reuters) - Aclarion Inc   :   * ACLARION INC - MAY OFFER, SELL SHARES OF COMMON STOCK OF UP TO $1.1 MILLION FROM TIME TO TIMESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2470447550","title":"Aclarion Announces at the Market Offering of up to $10 Mln of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2470447550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470447550?lang=en_us&edition=fundamental","pubTime":"2024-09-25 05:00","pubTimestamp":1727211631,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240924:nFWN3L60WE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2470144738","title":"Aclarion Inc - May Offer, Sell Shares of Common Stock of up to $1.1 Mln From Time to Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2470144738","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470144738?lang=en_us&edition=fundamental","pubTime":"2024-09-25 04:57","pubTimestamp":1727211441,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240924:nFWN3L60WD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","ACON"],"gpt_icon":0},{"id":"2467727839","title":"PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2467727839","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467727839?lang=en_us&edition=fundamental","pubTime":"2024-09-13 20:30","pubTimestamp":1726230600,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept. 13, 2024  -- PRISM MarketView presents an exclusive Q&A with Brent Ness, CEO and Director of Aclarion, Inc. . As a disruptive healthcare technology company focused on chronic low back pain, Aclarion is at the forefront of developing noninvasive tools to help physicians identify the source of pain in spinal discs, potentially revolutionizing the standard of care for this widespread and debilitating condition.Highlights from the Q&A:Nociscan’s Significant Role in Clinical Trials Ness highlighted Nociscan’s selection in the ongoing LIFEHAB Trial in Norway, a randomized controlled study comparing treatment outcomes for patients with chronic low back pain. The trial aims to evaluate how Nociscan’s magnetic resonance spectroscopy  biomarkers can assist in determining optimal treatment options. \"We are pleased with the progress and look forward to seeing the data further support the use of Nociscan in predicting treatment success,\" Ness said.About Aclarion, Inc.Aclarion is a h","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kgS2d5uZn3wdpBucsCrzmA--~B/aD02MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/79b35f500c6377e21ee36d84f1f9617c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kgS2d5uZn3wdpBucsCrzmA--~B/aD02MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/79b35f500c6377e21ee36d84f1f9617c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/prism-marketview-showcases-aclarion-disrupting-123000136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACON","BK4167","KOL","ACONW"],"gpt_icon":0},{"id":"2466220045","title":"Aclarion Provides Corporate Update on Nociscan AI Technology Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2466220045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466220045?lang=en_us&edition=fundamental","pubTime":"2024-09-12 18:57","pubTimestamp":1726138620,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240912:nTUA40Q9XN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACON","ACONW","BK4167"],"gpt_icon":0},{"id":"2466181435","title":"Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2466181435","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466181435?lang=en_us&edition=fundamental","pubTime":"2024-09-10 18:57","pubTimestamp":1725965820,"startTime":"0","endTime":"0","summary":"Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response. LIFEHAB is a Randomized Controlled Trial in Norway Comparing Lumbar Interbody Fusion Surgery With Multidisciplinary Rehabilitation. LIFEHAB Joins the NIH and Rome in Selecting Nociscan as a Technology to Help Determine Which Discs to Treat and the Technology’s Role in Selecting Optimal Treatment Options. Patient enrollment in LIFEHAB began in the second quarter of 2024. The initial enrolled patients began completing Nociscan exams in the last week of August. Thus far six  patients have completed their Nociscan exams.LIFEHAB is the latest customer-sponsored clinical trial involving Nociscan and the Company looks forward to announcing additional partnerships as Nociscan expands its adoption in the research mar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aclarion-announces-completion-first-nociscan-105700832.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACONW","ACON"],"gpt_icon":1},{"id":"2466529651","title":"Aclarion Inc Files for Mixed Shelf of up to $50 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2466529651","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466529651?lang=en_us&edition=fundamental","pubTime":"2024-09-09 18:02","pubTimestamp":1725876139,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240909:nFWN3KR0MO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","ACON"],"gpt_icon":0},{"id":"2465961127","title":"Aclarion Added to PRISM Emerging Medical Devices Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2465961127","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465961127?lang=en_us&edition=fundamental","pubTime":"2024-09-06 23:27","pubTimestamp":1725636420,"startTime":"0","endTime":"0","summary":"Company's industry-first technology addresses chronic low back pain. Aclarion secured its first commercial agreement with Michigan's Sheridan Community Hospital. PRISM Emerging Medical Devices Index features companies at forefront of innovation and market disruption in medtech. NEW YORK, Sept. 06, 2024  -- PRISM MarketView, a leading provider of market insights and company news, is excited to announce that Aclarion, Inc.  has been added to the PRISM Emerging Medical Devices Index, which highlights companies at the forefront of innovation and market disruption in the medtech sector. Aclarion’s innovative AI-driven diagnostic solutions for chronic low back pain position the company as a standout in the evolving medical devices sector.The U.S. medical devices market is projected to grow significantly, reaching an estimated value of nearly $315 billion by 2032. This expansion is driven by increasing R&D investments and a robust pipeline of innovations, including Aclarion’s NOCISCAN technol","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZodJNuhQdmSkJZH0KEFbQg--~B/aD0zNTg0O3c9NTM3NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/2ab0e5a076cc7edc7642cfb023f93df7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZodJNuhQdmSkJZH0KEFbQg--~B/aD0zNTg0O3c9NTM3NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/2ab0e5a076cc7edc7642cfb023f93df7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aclarion-added-prism-emerging-medical-152700050.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACON","ACONW","BK4167"],"gpt_icon":0},{"id":"2465570255","title":"Joseph Reda Reports Passive Stake of 9.9% in Aclarion Inc as of August 27, 2024 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2465570255","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465570255?lang=en_us&edition=fundamental","pubTime":"2024-09-06 04:29","pubTimestamp":1725568181,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240905:nFWN3KN1Y1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2465541951","title":"Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2465541951","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465541951?lang=en_us&edition=fundamental","pubTime":"2024-09-05 18:57","pubTimestamp":1725533820,"startTime":"0","endTime":"0","summary":"Justin Kubeck, M.D. of Ocean Pain and Spine in Toms River, NJ Will Lead a Statewide Network of Providers That Use Nociscan to Better Serve This Important Segment of Low Back Pain Population. Average Settlement in New Jersey for Personal Injury Claims Involving the Neck and Back is $918,967. Justin Kubeck, MD, an orthopedic surgeon and founder of Ocean Pain and Spine in Toms River, NJ will initiate a focused effort to improve the objective evaluation of chronic low back pain patients throughout the complex personal injury and workers compensation system that aims to provide the right treatments and financial compensation to patients suffering from injury.Ryan Bond, Chief Strategy Officer of Aclarion, commented, “Once established in New Jersey, we will target other markets throughout the United States to replicate the success of the NJ market. We believe this population is the perfe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aclarion-launches-surgeon-partnership-apply-105700192.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACON","ACONW","BK4167"],"gpt_icon":0},{"id":"2463872235","title":"Aclarion Launches Second Clinical Utility and Economic (Clue) Trial Site With First Surgeon in New Jersey","url":"https://stock-news.laohu8.com/highlight/detail?id=2463872235","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463872235?lang=en_us&edition=fundamental","pubTime":"2024-08-29 18:57","pubTimestamp":1724929020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240829:nTUA5WWW4Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACON","ACONW","BK4167"],"gpt_icon":0},{"id":"2463871239","title":"Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey","url":"https://stock-news.laohu8.com/highlight/detail?id=2463871239","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463871239?lang=en_us&edition=fundamental","pubTime":"2024-08-29 18:57","pubTimestamp":1724929020,"startTime":"0","endTime":"0","summary":"CLUE is a Multi-center Trial to Identify how Often Nociscan’s AI Data Changes the Initial Treatment Plan for Patients With Chronic Low Back Pain. Dr. Justin Kubeck Will Initiate CLUE in New Jersey at Ocean Pain and Spine in Toms River. Dr. Kubeck is the second surgeon to join CLUE since the trial was announced earlier this month, joining Dr. John Keller, a neurosurgical spine surgeon in Michigan. The Company expects a steady cadence of spine surgeons to join CLUE in the coming months to rapidly provide compelling data to payers as to how frequently Nociscan has a significant impact on the decision-making process during the critical stage when surgeons are planning the optimal treatment for their patient.\"Real world evidence is incredibly valuable when evaluating the influence and utility of an emerging diagnostic tool and when this evidence can be rapidly secured by experienced surgeons through a trial like CLUE, it becomes a critical tool for driving early payer coverage decisions,” s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aclarion-launches-second-clinical-utility-105700549.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4167","ACON","ACONW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aclarion.com","stockEarnings":[{"period":"1week","weight":0.0765},{"period":"1month","weight":-0.0689},{"period":"3month","weight":-0.2675},{"period":"6month","weight":-0.4374},{"period":"1year","weight":-0.9593},{"period":"ytd","weight":-0.9451}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.","exchange":"NASDAQ","name":"ACLARION, INC","nameEN":"ACLARION, INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ACLARION, INC(ACON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ACLARION, INC(ACON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ACLARION, INC,ACON,ACLARION, INC股票,ACLARION, INC股票老虎,ACLARION, INC股票老虎国际,ACLARION, INC行情,ACLARION, INC股票行情,ACLARION, INC股价,ACLARION, INC股市,ACLARION, INC股票价格,ACLARION, INC股票交易,ACLARION, INC股票购买,ACLARION, INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ACLARION, INC(ACON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ACLARION, INC(ACON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction